Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Partnership for Hematology Instruments

By Labmedica staff writers
Posted on 23 Feb 2005
An agreement for the commercialization of automated hematology diagnostic instruments has been announced by Abbott Laboratories (Abbott Park, IL, USA) and Nihon Kohden Corp. More...
(Tokyo, Japan), whereby the instruments will be manufactured by Nihon Kohden and distributed by Abbott.

Under the terms of the agreement, two five-part differential hematology instruments, designed to offer red and white blood cell analysis, will be manufactured by Nihon Kohden, a leading manufacturer of patient monitors, electrocardiographs, defibrillators, and hematology analyzers. Abbott will have exclusive distribution rights for the two instruments in the United States and Canada and nonexclusive distribution rights for all other countries except China and Japan. Abbott markets a line of hematology instruments that provide fast access to patient results.

"A key part of the agreement was the commitment both companies have to improving patient care through scientific advances in medical technology,” noted Harold Flynn, divisional vice president and general manager, hematology, at Abbott. "Nihon Kohden's innovative technology in blood analysis complements Abbott's capabilities and proprietary technology.”





Related Links:
Abbott
Nihon Kohden

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.